Warby Parker price to free cash flow WRBY

Market value divided by free cash flow over the last twelve months, since 2023.

Today, Oct 23, 2026: 147×
3-year median: 82.5×
Against its 3-year history: 90th; percentile: 0 is its lowest day, 100 its highest
3-year range: 45.1× to 220×
Peer median: 26.2×

Warby Parker's price to free cash flow is 147× as of Oct 23, 2026.

That is above its 3-year median of 82.5×, higher than on 90% of days in the last 3 years.

Over that time it ranged from 45.1× in May 2025 to 220× in Mar 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 26.2×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	147×	56.8×	156×
2025	78.2×	45.1×	102×
2024	90.1×	65.4×	220×
2023	98.4×	70.2×	98.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Warby Parker's size, closest first, today.

Company	Price to free cash flow
WRBYWarby Parker	147×
ATRCAtriCure	56.5×
NVSTEnvista	15.3×
ICUIICU Medical	27.3×
BMIBadger Meter	29.2×
UFPTUFP Technologies	n/m
VNTVontier	12.1×
INSPInspire Medical Systems	17.6×
LMATLemaitre Vascular	26.2×
HAEHaemonetics	18.5×
MMSIMerit Medical Systems	27.4×
Peer median	26.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Warby Parker

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.